432 related articles for article (PubMed ID: 10336877)
1. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
3. Characterization of variant diphtheria toxin-interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials.
Su Y; Li SY; Ghosh S; Ortiz J; Hogge DE; Frankel AE
Biologicals; 2010 Jan; 38(1):144-9. PubMed ID: 19783458
[TBL] [Abstract][Full Text] [Related]
4. GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.
Woo JH; Liu JS; Kang SH; Singh R; Park SK; Su Y; Ortiz J; Neville DM; Willingham MC; Frankel AE
Protein Expr Purif; 2008 Mar; 58(1):1-11. PubMed ID: 18160309
[TBL] [Abstract][Full Text] [Related]
5. Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies.
Williams MD; Rostovtsev A; Narla RK; Uckun FM
Protein Expr Purif; 1998 Jul; 13(2):210-21. PubMed ID: 9675065
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
Frankel AE; Powell BL; Hall PD; Case LD; Kreitman RJ
Clin Cancer Res; 2002 May; 8(5):1004-13. PubMed ID: 12006512
[TBL] [Abstract][Full Text] [Related]
7. [Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines].
Tuo HZ; Wang JW; Wang DX; Li JM; Ouyang J; Hong T
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1024-8. PubMed ID: 15312540
[TBL] [Abstract][Full Text] [Related]
8. High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil.
Sun QM; Jiang HC; Xu WM; Liu X; Dai CB; Sun MS
Protein Expr Purif; 2005 Aug; 42(2):278-85. PubMed ID: 15935697
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
10. Toxicology and pharmacokinetics of DT388-GM-CSF, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor (GM-CSF) in C57BL/6 mice.
Hall PD; Kreitman RJ; Willingham MC; Frankel AE
Toxicol Appl Pharmacol; 1998 May; 150(1):91-7. PubMed ID: 9630457
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia.
Hall PD; Virella G; Willoughby T; Atchley DH; Kreitman RJ; Frankel AE
Clin Immunol; 2001 Aug; 100(2):191-7. PubMed ID: 11465948
[TBL] [Abstract][Full Text] [Related]
12. In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor.
Perentesis JP; Gunther R; Waurzyniak B; Yanishevski Y; Myers DE; Ek O; Messinger Y; Shao Y; Chelstrom LM; Schneider E; Evans WE; Uckun FM
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2217-27. PubMed ID: 9815618
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein.
Wen Q; Ma L; Luo W; Zhou MQ; He D; Lin Y; Wu ZQ; He XW; Wang JF; Wang XN
Biotechnol Appl Biochem; 2008 May; 50(Pt 1):41-8. PubMed ID: 17708750
[TBL] [Abstract][Full Text] [Related]
14. [Expression, purification and identification of mouse granulocyte-macrophage colony-stimulating factor].
Wen Q; Ma L; Su J; Luo W; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1124-7. PubMed ID: 16939899
[TBL] [Abstract][Full Text] [Related]
15. [Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein].
Yao LL; Wang JN; Huang YZ; Guo LY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1319-25. PubMed ID: 16982446
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of recombinant truncated human interleukin-11 expressed as fusion protein in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Jul; 27(13):905-10. PubMed ID: 16091884
[TBL] [Abstract][Full Text] [Related]
17. [Design and expression of a diphtheria toxin hybrid protein and human interleukin-2 gene in Escherichia coli].
Shemiakin IG; Anisimova VA; Mitrofanova GN
Mol Biol (Mosk); 1992; 26(5):1088-98. PubMed ID: 1470175
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice.
Black JH; McCubrey JA; Willingham MC; Ramage J; Hogge DE; Frankel AE
Leukemia; 2003 Jan; 17(1):155-9. PubMed ID: 12529673
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF.
Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ
Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951
[TBL] [Abstract][Full Text] [Related]
20. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
